Elicio Therapeutics Ownership | Who Owns Elicio Therapeutics?

Elicio Therapeutics Ownership Summary

Elicio Therapeutics is owned by 4.92% institutional investors, 29.76% insiders, and 65.32% retail investors. Knoll capital management is the largest institutional shareholder, holding 4.12% of ELTX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.18% of its assets in Elicio Therapeutics shares.

ELTX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Elicio Therapeutics	4.92%	29.76%	65.32%
Sector	Healthcare Stocks	50.53%	12.40%	37.07%
Industry	Biotech Stocks	48.96%	12.12%	38.92%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Knoll capital management	630.91K	4.12%	$6.74M
Vanguard group	496.90K	2.98%	$3.96M
Geode capital management	135.16K	0.88%	$1.45M
Vanguard fiduciary trust	69.19K	0.45%	$739.63K
Northern trust	59.73K	0.39%	$638.56K
State street	50.62K	0.33%	$541.13K
Blackrock funding, inc. /de	50.60K	0.33%	$540.88K
Ubs group	33.77K	0.22%	$360.99K
Morgan stanley	32.40K	0.21%	$346.40K
Meyer handelman	13.90K	0.09%	$148.58K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Knoll capital management	630.91K	3.74%	$6.74M
Mayflower financial advisors	10.00K	0.01%	$106.90K
Moody lynn & lieberson	10.00K	0.01%	$106.90K
Meyer handelman	13.90K	0.00%	$148.58K
Summit financial	10.01K	0.00%	$107.01K
Hb wealth management	10.46K	0.00%	$111.85K
Wiley bros.-aintree capital	10.00K	0.00%	$106.90K
Vanguard fiduciary trust	69.19K	0.00%	$739.63K
Geode capital management	135.16K	0.00%	$1.45M
Cibc private wealth group	7.00K	0.00%	$55.72K

Top Buyers

Holder	Shares	% Assets	Change
Vanguard fiduciary trust	69.19K	0.00%	69.19K
Vanguard group	496.90K	0.00%	23.04K
Morgan stanley	32.40K	-	17.85K
Raymond james financial	11.10K	-	11.10K
Hb wealth management	10.46K	0.00%	10.46K

Top Sellers

Holder	Shares	% Assets	Change
Balyasny asset management	-	-	-244.81K
Renaissance	-	-	-121.63K
Millennium management	-	-	-92.76K
Marshall wace, llp	-	-	-74.51K
Susquehanna group, llp	-	-	-70.80K

New Positions

Holder	Shares	% Assets	Change	Value
Vanguard fiduciary trust	69.19K	0.00%	69.19K	$739.63K
Raymond james financial	11.10K	-	11.10K	$118.66K
Hb wealth management	10.46K	0.00%	10.46K	$111.85K
Vanguard global advisers	4.42K	-	4.42K	$47.21K
Tower research capital llc (trc)	1.00	-	1.00	$11.00

Sold Out

Holder	Change
Caitong asset management	-3.00
Jpmorgan chase	-16.00
Fortitude family office	-93.00
Simplex trading	-103.00
Wells fargo & company/mn	-200.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	16	-60.00%	753,220	-63.78%	4	3.17%	10	-56.52%	1	-85.71%
Dec 31, 2025	25	-21.88%	1,060,602	-45.42%	6	4.34%	16	-20.00%	2	-
Sep 30, 2025	31	34.78%	1,936,273	33.46%	12	14.77%	20	100.00%	2	-60.00%
Jun 30, 2025	23	-4.17%	1,450,816	-8.85%	9	5.98%	10	-41.18%	5	150.00%
Mar 31, 2025	24	41.18%	1,591,744	250.55%	12	88.77%	17	325.00%	2	-66.67%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	415.40K	2.18%	30.60K
Vanguard MStar Total Stk Mkt Idx Invest	415.40K	1.90%	-
Vanguard Morn Total Stk Mkt Idx Investor	415.40K	1.58%	30.60K
iShares Russell 2000 ETF	311.79K	1.19%	-5.57K
Vanguard Institutional Extnd Mkt Idx Tr	143.60K	0.66%	-
Russell 2000 Equity Index Fund B	104.70K	0.55%	104.70K
Russell 2000 Index Non-Lendable Fund	104.70K	0.55%	104.70K
Halley Alinea Global A	90.72K	0.48%	29.43K
iShares Russell 2000 Growth ETF	118.75K	0.45%	-1.08K
State St Russell Sm/Mid Cp® Indx SL Cl I	76.00K	0.35%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 12, 2024	Chudnovsky Yekaterina		Buy	$20.00M
Jun 28, 2024	Venkatesan Jay	-	Buy	$250.00K
Jun 28, 2024	Venkatesan Jay	-	Buy	$500.00
Jun 28, 2024	Chudnovsky Yekaterina		Buy	$8.00M
Jun 28, 2024	Chudnovsky Yekaterina		Buy	$16.00K

Insider Transactions Trends

Date	Buy	Sell
2026 Q3	-	-
2026 Q1	-	-
2025 Q4	-	-
2025 Q2	-	-
2025 Q1	-	-

ELTX Ownership FAQ

Who Owns Elicio Therapeutics?

Elicio Therapeutics shareholders are primarily institutional investors at 4.92%, followed by 29.76% insiders and 65.32% retail investors. The average institutional ownership in Elicio Therapeutics's industry, Biotech Stocks , is 48.96%, which Elicio Therapeutics falls below.

Who owns the most shares of Elicio Therapeutics?

Elicio Therapeutics’s largest shareholders are Knoll capital management (630.92K shares, 4.12%), Vanguard group (496.9K shares, 2.98%), and Geode capital management (135.16K shares, 0.88%). Together, they hold 7.98% of Elicio Therapeutics’s total shares outstanding.

Does Blackrock own Elicio Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Elicio Therapeutics.

Who is Elicio Therapeutics’s biggest shareholder by percentage of total assets invested?

Knoll capital management is Elicio Therapeutics’s biggest shareholder by percentage of total assets invested, with 3.74% of its assets in 630.92K Elicio Therapeutics shares, valued at 6.74M$.

Who is the top mutual fund holder of Elicio Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Elicio Therapeutics shares, with 2.18% of its total shares outstanding invested in 415.4K Elicio Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools